Target
Free fatty acid receptor 1
Ligand
BDBM300832
Substrate
n/a
Meas. Tech.
GPR40 Calcium Flux Assay
EC50
6.00±n/a nM
Citation
 Huang, HKuo, GPlayer, MRYang, SZhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US10131648 Publication Date 11/20/2018 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300832
Synonyms:
2-(3-Oxo-1-(4-((3-(2- methylphenyl) benzo[b]thiophen-5- yl)methoxy)phenyl)cyclobutyl) acetic acid | US10131648, Compound 30 | US10195178, Compound 30 | US9790198, Compound 30
Type:
Small organic molecule
Emp. Form.:
C28H24O4S
Mol. Mass.:
456.553
SMILES:
Cc1ccccc1-c1csc2ccc(COc3ccc(cc3)C3(CC(O)=O)CC(=O)C3)cc12
Structure:
Search PDB for entries with ligand similarity: